| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/26/2002 | EP1105383A4 Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives |
| 06/26/2002 | EP1051155B1 Nasal solutions |
| 06/26/2002 | EP0912895A4 Method for monitoring t-cell reactivity |
| 06/26/2002 | EP0906096B1 Use of hydroxyprolines for the manufacture of a medicament for inhibiting leukocyte invasion of tissues |
| 06/26/2002 | EP0820441B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS |
| 06/26/2002 | EP0764029B1 Proteinaceous adjuvants |
| 06/26/2002 | EP0644773B1 Anti-aids immunomodulator complex |
| 06/26/2002 | EP0464147B1 Matrix metalloproteinase inhibitor peptides |
| 06/26/2002 | CN1355852A T cell receptor Vbeta-Dbeta-Jbeta sequence and methods for its detection |
| 06/26/2002 | CN1355846A Method for down-regulating IL5 activity |
| 06/26/2002 | CN1355809A Immunomodulatory steroids, in particular hemihydrate of 16 alpha-bromoepiandrosterone |
| 06/26/2002 | CN1355799A 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 06/26/2002 | CN1355782A Benzene derivatives, preparation method and pharmaceutical compositions containing same |
| 06/26/2002 | CN1355712A Use of antibodies against CD2O for treatment of graft versus host disease |
| 06/26/2002 | CN1355710A Combination vaccine against streptocouus pneumoniae and repiratory syncytial virus (RSV) |
| 06/26/2002 | CN1355701A Urea substituted imidazoquinolines |
| 06/26/2002 | CN1355171A Extracting process and usage of general aralic chinensis saponin |
| 06/26/2002 | CN1355039A Natural medicine for repairing gene and regulating and improving immunity |
| 06/26/2002 | CN1086694C 17-side chain ankynyl-and 20-oxopregna-derivatives of vitamin D, prodn. and pharmaceutical composition thereof |
| 06/26/2002 | CN1086589C Vaccines |
| 06/25/2002 | US6410791 Salbutamol; respiratory system disorders |
| 06/25/2002 | US6410787 Process to prepare 2-aminoindan derivatives |
| 06/25/2002 | US6410752 Tocopherol derivatives and method for preparation thereof |
| 06/25/2002 | US6410709 Polypeptide; for use in diagnosis and treatment of inflammatory and cell proliferative disorders |
| 06/25/2002 | US6410691 Monoclonal antibody for use in diagnosis and treatment of immunlogical defects, cancer and rheumatic diseases |
| 06/25/2002 | US6410690 Therapeutic compounds comprised of anti-Fc receptor antibodies |
| 06/25/2002 | US6410688 Def1 |
| 06/25/2002 | US6410590 Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them |
| 06/25/2002 | US6410553 Benzosulfones and related compositions and methods |
| 06/25/2002 | US6410552 Benzoether and related compositions and methods |
| 06/25/2002 | US6410551 Bronchodilator |
| 06/25/2002 | US6410546 Aids therapy |
| 06/25/2002 | US6410509 Antigen; induce immunology response |
| 06/25/2002 | US6410318 Antibodies directed against binding-associated epitopes |
| 06/25/2002 | US6410316 Methods for producing a vector producing cell line utilizing a high multiplicity of transduction |
| 06/25/2002 | US6410289 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 06/25/2002 | US6410222 Immuniizng chicken eggs |
| 06/25/2002 | US6410028 Administering complex of heat shock protein noncovalently bound to antigenic peptide or protein to elicit immune response, wherein complex is made in vitro, and antigenic peptide or protein is not isolated from complex |
| 06/25/2002 | CA2240964C Piperidone tachykinin antagonists |
| 06/25/2002 | CA2220024C Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents |
| 06/25/2002 | CA2201587C Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 06/21/2002 | CA2363799A1 Novel methods for using alkanoyloxymethyl esters |
| 06/20/2002 | WO2002048397A2 Regulation of human adenylate cyclase, type vii |
| 06/20/2002 | WO2002048368A2 Proteins associated with cell growth, differentiation, and death |
| 06/20/2002 | WO2002048358A2 Regulation of human chemokine-like receptor |
| 06/20/2002 | WO2002048337A2 Secreted human proteins |
| 06/20/2002 | WO2002048184A2 Glycoprotein peptide of the human herpesvirus-7 for use in particular in an elisa serologic test |
| 06/20/2002 | WO2002048182A2 Interferon-alpha induced gene |
| 06/20/2002 | WO2002048180A2 Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament |
| 06/20/2002 | WO2002048167A1 Method for generating immortal dendritic cell lines |
| 06/20/2002 | WO2002048165A2 Antiviral agents for treatment of flaviviridae infections |
| 06/20/2002 | WO2002048145A1 Aminotriazolopyridiine derivatives as adenosine receptor ligands |
| 06/20/2002 | WO2002048136A1 Keratinocyte proliferation inhibitors |
| 06/20/2002 | WO2002048117A1 Quinazolinone derivatives |
| 06/20/2002 | WO2002048114A1 Phenylacetamido- pyrazole derivatives and their use as antitumor agents |
| 06/20/2002 | WO2002048096A1 Hydrazone derivatives and use thereof in medicines |
| 06/20/2002 | WO2002047762A1 Serine protease inhibitors |
| 06/20/2002 | WO2002047721A1 Silensed anti-cd28 antibodies and use thereof |
| 06/20/2002 | WO2002047711A2 Modulators of activity of g-protein-coupled receptor kinases |
| 06/20/2002 | WO2002047708A2 Selective cox-2 inhibition from edible plant extracts |
| 06/20/2002 | WO2002047705A2 Compositions containing an active fraction isolated from tricholoma conglobatum and methods of use |
| 06/20/2002 | WO2002047704A1 Herbal pharmaceutical compositions for treating immunological disorders |
| 06/20/2002 | WO2002047703A2 Immune system stimulation |
| 06/20/2002 | WO2002047689A2 Use of cetirizine or efletirizine for preventing urticaria |
| 06/20/2002 | WO2002047686A1 Substituted-4-quinolones |
| 06/20/2002 | WO2002047673A2 Methods and compositions to treat conditions associated with neovascularization |
| 06/20/2002 | WO2002047656A1 Compositions for retarding skin aging |
| 06/20/2002 | WO2002047534A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 06/20/2002 | WO2002031110A3 Hematopoietic stem cell gene therapy |
| 06/20/2002 | WO2002030888A3 Tricyclic compounds and uses thereof |
| 06/20/2002 | WO2002030320A3 Stimulation of thymus for vaccination development |
| 06/20/2002 | WO2002028905A3 Human anti-cd40 antibodies |
| 06/20/2002 | WO2002020495A3 Inhibitors of glycogen synthase kinase 3 |
| 06/20/2002 | WO2002020013A3 A method for treating allergies using substituted pyrazoles |
| 06/20/2002 | WO2002016436A3 ANTIBODIES TO HUMAN IL-1$g(b) |
| 06/20/2002 | WO2002012214A3 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 06/20/2002 | WO2002008291A3 Multi-specific reagent for selective stimulation of cell surface receptors |
| 06/20/2002 | WO2002003911A8 Prevention and treatment of alzheimer's disease |
| 06/20/2002 | WO2002003910A3 Antibacterial, antioxidant, immunomoduling and anticancerogenic preparation and method for using said preparation |
| 06/20/2002 | WO2002000232A3 Methods and compositions for developing spore display systems for medicinal and industrial applications |
| 06/20/2002 | WO2001087977A3 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci |
| 06/20/2002 | WO2001085942A3 Cytoskeleton-associated proteins |
| 06/20/2002 | WO2001085096A3 Mast cell regulation |
| 06/20/2002 | WO2001083524A3 Rna metabolism proteins |
| 06/20/2002 | WO2001079487A3 Polydesoxyribonucleotides for inhibiting the expression of the icam-1-gene |
| 06/20/2002 | WO2001072830A3 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction |
| 06/20/2002 | WO2001051633A3 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 06/20/2002 | WO2001044445A8 Human lyases and associated proteins |
| 06/20/2002 | WO2001036448A8 Preparation and composition of peptides useful for treatment of autoimmune and transplant related graft versus host conditions |
| 06/20/2002 | WO2001003688A3 Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds |
| 06/20/2002 | WO2000067734A3 Use of phthalazine derivatives |
| 06/20/2002 | WO2000061750A9 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS |
| 06/20/2002 | WO2000061596A8 50 human secreted proteins |
| 06/20/2002 | US20020077482 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 06/20/2002 | US20020077460 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 06/20/2002 | US20020077360 Administering to a mammal a retinoid campound which binds specifically or selectively to a RAR alpha retinoid receptors in preference over RAR beta and RAR Gamma retinoid receptors, for therapy and prophylaxisof disease or condition |
| 06/20/2002 | US20020077357 For therapy of autoimmune disease |
| 06/20/2002 | US20020077356 Nonsteroidal antiinflammatory agents |
| 06/20/2002 | US20020077351 For therapy and prophylaxis of diseases such as cachexia attributed to cancer or infections, rheumatoid arthritis, inflammatory diseases, osteoarthritis, systemic lupus erythematosus, rejection during bone marrow transplantation |
| 06/20/2002 | US20020077337 Chemical compounds |